Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Cutan Pathol ; 45(11): 817-823, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30039546

ABSTRACT

BACKGROUND: Graft-versus-host disease (GVHD) following solid organ transplantation (SOT) is extremely rare and infrequently described in the dermatologic literature. METHODS: We performed a retrospective clinicopathologic review of our institution's experience with patients diagnosed with SOT-associated GVHD (SOT GVHD) (May 1, 1996 to September 1, 2017). RESULTS: Of nine patients with SOT GVHD, seven had undergone liver transplantation, while two had undergone lung transplantation. All presented initially with a skin eruption, which developed an average of 63 days (range: 11-162 days) post transplant. The average time to diagnosis following the onset of the skin eruption was 12 days (range: 0-54 days). Diagnosis was often delayed because of a competing diagnosis of drug reaction. Frequent skin findings included pruritic erythematous to violaceous macules and papules with desquamation. Histopathology showed vacuolar interface dermatitis in 12 of 15 cases (80.0%). Of the 11 specimens in which a hair follicle was present for evaluation, vacuolar interface changes around the hair follicle were present in eight (72.7%) cases. Seven patients (77.8%) died from complications during the follow-up period. CONCLUSIONS: SOT GVHD presents initially with skin involvement, is associated with vacuolar interface changes on skin biopsy, and is associated with a high mortality rate. Clinicopathologic correlation is required for accurate diagnosis.


Subject(s)
Graft vs Host Disease/pathology , Organ Transplantation/adverse effects , Skin Diseases/pathology , Adult , Aged , Female , Graft vs Host Disease/mortality , Humans , Male , Middle Aged , Retrospective Studies , Young Adult
2.
J Am Acad Dermatol ; 78(6): 1097-1101.e1, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29288097

ABSTRACT

BACKGROUND: Graft-versus-host-disease (GVHD) after solid organ transplantation (SOT) is extremely rare. OBJECTIVE: To investigate the dermatologic manifestations and clinical outcomes of SOT GVHD. METHODS: Systematic literature review of SOT GVHD. RESULTS: After full-text article review, we included 61 articles, representing 115 patients and 126 transplanted organs. The most commonly transplanted organ was the liver (n = 81). Among 115 patients, 101 (87.8%) developed skin involvement. The eruption appeared an average of 48.3 days (range, 3-243 days) posttransplant and was pruritic in 5 of 101 (4.9%) cases. The eruption was described as morbilliform in 2 patients (1.9%), confluent in 6 (5.9%), and desquamative in 4 (3.9%) cases. In many cases, specific dermatologic descriptions were lacking. The mortality rate was 72.2%. Relative time of death was reported in 23 patients who died during the follow-up period. These patients died an average of 99.2 days (range, 22-270 days) posttransplant, or 50.9 days after the appearance of dermatologic symptoms. Frequent causes of death were sepsis and multiorgan failure. LIMITATIONS: Incomplete descriptions of skin findings and potential publication bias resulting in publication of only the most severe cases. CONCLUSIONS: GVHD is a potentially fatal condition that can occur after SOT and often presents with a skin rash. We recommend that dermatologists have a low threshold to consider and pursue this diagnosis in the setting of post-SOT skin eruption.


Subject(s)
Graft vs Host Disease/etiology , Organ Transplantation/adverse effects , Skin Diseases/etiology , Female , Graft Rejection , Graft Survival , Graft vs Host Disease/physiopathology , Humans , Kidney Transplantation/adverse effects , Kidney Transplantation/methods , Liver Transplantation/adverse effects , Liver Transplantation/methods , Lung Transplantation/adverse effects , Lung Transplantation/methods , Male , Organ Transplantation/methods , Prognosis , Risk Assessment , Severity of Illness Index , Skin Diseases/physiopathology , Survival Analysis
3.
J Psychiatr Pract ; 19(2): 87-97, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23507810

ABSTRACT

Many deaf individuals comprise a unique cultural and linguistic minority group. This article reviews the current research literature related to the evaluation, diagnosis, and treatment of culturally deaf individuals suffering from mental disorders. Appropriate psychiatric assessment and treatment requires that clinicians be sensitive to issues of language and differences in social norms and cultural values. Emerging trends in research indicate greater diagnostic specificity and a broader range of diagnoses being assigned in services that are specialized for the treatment of deaf people with mental health issues. Culturally sensitive evaluation and treatment involves a thorough assessment of language modality and language fluency, deafness/audiological history, and cultural identification. Failure to consider these factors during the mental status exam can lead to misdiagnosis. Important issues that confound differential diagnosis and psychiatric treatment of the deaf population are highlighted and discussed. Recommendations for the provision of culturally and linguistically appropriate care are provided.


Subject(s)
Deafness , Mental Disorders , Persons With Hearing Impairments/psychology , Sign Language , Symptom Assessment/methods , Adult , Comorbidity , Cultural Diversity , Deafness/diagnosis , Deafness/ethnology , Deafness/etiology , Deafness/psychology , Humans , Mental Disorders/epidemiology , Mental Disorders/physiopathology , Persons With Hearing Impairments/rehabilitation , Psychoacoustics , Psycholinguistics/methods , Symptom Assessment/psychology , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...